Nucor Corporation (NUE) Stock Forecast
Data as of Jun 16, 2026Basic Materials · Current price $259.60 (+0.11%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Jan 28, 2026 | Andrew Jones | UBS | $183.00 | -29.5% |
| Jan 9, 2026 | Carlos De Alba | Morgan Stanley | $180.00 | -30.7% |
| Dec 18, 2025 | Timna Tanners | Wells Fargo | $176.00 | -32.2% |
| Oct 29, 2025 | Timna Tanners | Wells Fargo | $147.00 | -43.4% |
| Oct 28, 2025 | Carlos De Alba | Morgan Stanley | $165.00 | -36.4% |
| Mar 24, 2025 | Carlos De Alba | Morgan Stanley | $164.00 | -36.8% |
| Mar 24, 2025 | Andrew Jones | UBS | $160.00 | -38.4% |
| Feb 3, 2025 | Carlos De Alba | Morgan Stanley | $154.00 | -40.7% |
| Oct 29, 2024 | John Eade | Argus Research | $160.00 | -38.4% |
| Oct 22, 2024 | Matthew Miller | CFRA | $129.00 | -50.3% |
| Sep 18, 2024 | Carlos De Alba | Morgan Stanley | $170.00 | -34.5% |
| Sep 18, 2024 | Katja Jancic | BMO Capital | $160.00 | -38.4% |
| Aug 15, 2024 | Carlos De Alba | Morgan Stanley | $176.00 | -32.2% |
| Jun 17, 2024 | Katja Jancic | BMO Capital | $175.00 | -32.6% |
| Jun 14, 2024 | Christopher LaFemina | Jefferies | $170.00 | -34.5% |
| May 20, 2024 | Christopher LaFemina | Jefferies | $190.00 | -26.8% |
| May 4, 2022 | David Coleman | Argus Research | $190.00 | -26.8% |
| Apr 22, 2022 | David Gagliano | BMO Capital | $168.00 | -35.3% |
| Apr 14, 2022 | Michael Glick | J.P. Morgan | $129.00 | -50.3% |
| Jun 4, 2021 | Andreas Bokkenheuser | UBS | $110.00 | -57.6% |
Top Analysts Covering NUE
NUE vs Sector & Market
| Metric | NUE | Basic Materials Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.24 | 2.37 | 2.40 |
| Analyst Count | 17 | 7 | 19 |
| Target Upside | -9.2% | +90.8% | +17.1% |
| P/E Ratio | 25.70 | -10.31 | 31.64 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $33.87B | $36.36B | $38.27B | 10 |
| 2027-12-31 | $36.42B | $37.80B | $39.52B | 9 |
| 2028-12-31 | $38.68B | $38.87B | $39.05B | 6 |
| 2029-03-31 | $9.86B | $10.30B | $10.69B | 5 |
| 2029-06-30 | $10.19B | $10.65B | $11.04B | 4 |
| 2029-09-30 | $9.99B | $10.44B | $10.83B | 4 |
| 2029-12-31 | $9.30B | $9.73B | $10.09B | 5 |
| 2030-03-31 | $9.59B | $10.02B | $10.39B | 3 |
| 2030-06-30 | $10.13B | $10.58B | $10.98B | 3 |
| 2030-09-30 | $9.76B | $10.20B | $10.58B | 3 |
| 2030-12-31 | $9.28B | $9.70B | $10.06B | 3 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $11.42 | $12.73 | $14.51 | 7 |
| 2027-12-31 | $12.88 | $14.10 | $15.52 | 8 |
| 2028-12-31 | $13.98 | $14.87 | $16.61 | 4 |
| 2029-03-31 | $3.60 | $3.81 | $3.99 | 4 |
| 2029-06-30 | $3.91 | $4.14 | $4.34 | 3 |
| 2029-09-30 | $3.72 | $3.94 | $4.13 | 3 |
| 2029-12-31 | $3.04 | $3.22 | $3.37 | 4 |
| 2030-03-31 | $4.02 | $4.25 | $4.46 | 2 |
| 2030-06-30 | $4.39 | $4.66 | $4.88 | 2 |
| 2030-09-30 | $3.96 | $4.20 | $4.40 | 2 |
| 2030-12-31 | $3.39 | $3.59 | $3.77 | 2 |
Frequently Asked Questions
What is the analyst consensus for NUE?
The consensus among 17 analysts covering Nucor Corporation (NUE) is Buy with an average price target of $179.67.
What is the highest price target for NUE?
The highest price target for NUE is $190.00, set by Christopher LaFemina at Jefferies on 2024-05-20.
What is the lowest price target for NUE?
The lowest price target for NUE is $110.00, set by Andreas Bokkenheuser at UBS on 2021-06-04.
How many analysts cover NUE?
17 analysts have issued ratings for Nucor Corporation in the past 12 months.
Is NUE a buy or sell right now?
Based on 17 analyst ratings, NUE has a consensus rating of Buy (2.24/5) with a -9.2% upside to the consensus target of $179.67.
What are the earnings estimates for NUE?
Analysts estimate NUE will report EPS of $12.73 for the period ending 2026-12-31, with revenue estimated at $36.36B.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.